United States· US:25021-410_89603c04-9b00-4528-8668-b8489308380f
Enoxaparin Sodium
A medicinal product containing enoxaparin sodium, registered in United States by Sagent Pharmaceuticals.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ENOXAPARIN SODIUM
- Manufacturer
- Sagent Pharmaceuticals
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 5
- ndc1125021-410-70
- ndc1125021-410-71
- ndc1125021-410-76
- ndc1125021-410-77
- ndc1125021-410-78
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Enoxaparin sodium in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCLEXANESanofi s.r.o., Praha
- BelgiumClexane 10000 IU (100 mg)/1 mlSanofi Belgium
- CanadaAXBERIBAXTER CORPORATION
- IrelandClexane 10,000 IU (100 mg)/1 ml Solution for Injection in pre-filled syringesPCO Manufacturing Ltd.
- FinlandEnoxaparin BecatLaboratorios Farmacéuticos Rovi S.A.
- GermanyClexaneSanofi-Aventis Deutschland Gmbh
- SwedenEnoxaparin Becat 10 000 IE (100 mg)/1 ml Injektionsvätska, lösning i förfylld sprutaLaboratorios Farmacéuticos ROVI S.A.
- NorwayInhixaTechdow Pharma Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Belgium · Clexane, Enoxaparine Becat Laboratorios Farmacéuticos Rovi
- Bulgaria · Клексан
- Cyprus · Clexane, Ledraxen
- Czechia · Clexane, Clexane Forte
- Germany · Clexane, Clexane Klinik
- Denmark · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Estonia · Clexane, Ledraxen
- Spain · Clexane, Crusia
- Finland · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- France · Crusia, Enoxaparine Arrow
- United Kingdom (Northern Ireland) · Arovi, Clexane Forte Syringes
- Greece · Clexane, Enoxaparin Rovi
- Croatia · Clexane, Ledraxen
- Hungary · Clexane, Clexane Forte
- Ireland · Clexane, Clexane Forte
- Iceland · Inhixa, Klexane
- Italy · Clexane, Clexane T
- Lithuania · Ledraxen
- Luxembourg · Clexane, Clexane 6 000 Ui
- Latvia · Clexane, Ledraxen
- Malta · Clexane, Clexane 2,000 Iu
- Netherlands · Enoxaparine Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Norway · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Poland · Clexane, Clexane Forte
- Portugal · Enoxaparina Rovi, Hepaxane
- Romania · Clexane, Hepaxane
- Sweden · Enoxaparin Becat Laboratorios Farmacéuticos Rovi, Ghemaxan
- Slovenia · Clexane, Enoksaparin Rovi
- Slovakia · Clexane, Clexane Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3f31d57-908e-4721-8844-0170e63e97b7 GET /v1/drugs/d3f31d57-908e-4721-8844-0170e63e97b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "100",
"substance": "ENOXAPARIN SODIUM",
"productndc": "25021-410",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA078990",
"marketing_category": "ANDA"
}See everything about enoxaparin sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.